Evaluation of hirsutism

Última revisão: 13 Sep 2025
Última atualização: 24 Jul 2025

Resumo

Diagnósticos diferenciais

comuns

  • Polycystic ovary syndrome
  • Idiopathic hirsutism
Detalhes completos

Incomuns

  • Hyperprolactinemia
  • Nonclassic congenital adrenal hyperplasia
  • Cushing syndrome
  • Androgenic drugs
  • Androgen-secreting ovarian tumor
  • Ovarian hyperthecosis
  • Adrenocortical carcinoma
Detalhes completos

Colaboradores

Autores

Stephen L. Atkin, PhD, FRCP

Professor of Medicine

Head of School of Postgraduate Studies & Research

The Royal College of Surgeons in Ireland - Bahrain

Busaiteen

Bahrain

Declarações

SLA has no competing interests.

Thozhukat Sathyapalan, MD, MRCP FRCPE

Professor of Endocrinology/Honorary Consultant Endocrinologist

Academic Endocrinology, Diabetes and Metabolism

Hull York Medical School

Michael White Diabetes Centre

Hull Royal Infirmary

Hull

UK

Declarações

TS declares that he has received educational grants and clinical trials funding from Novo Nordisk, Eli Lillly, and Novartis.

Agradecimentos

Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic.

Declarações

SB and MBB declared that they had no competing interests.

Revisores

Joe McKenna, MD

Professor of Investigative Endocrinology

University College

Dublin

Ireland

Declarações

JM declares that he has no competing interests.

Udaya Kabadi, MD, FRCP(C), FACP, FACE

Director

Endocrinology

Department of Internal Medicine

VA Medical Center

University of Iowa

Iowa City

IA

Declarações

UK declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233-57.Texto completo  Resumo

Elliott J, Liu K, Motan T. Guideline no. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can. 2023 Dec;45(12):102272. Resumo

Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023 Oct;120(4):767-93.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal